Publications by authors named "Nadiya Khyzha"

Whereas techniques to map chromatin-bound proteins are well developed, mapping chromatin-associated RNAs remains a challenge. Here, we describe Reverse Transcribe and Tagment (RT&Tag), in which RNAs associated with a chromatin epitope are targeted by an antibody followed by a protein A-Tn5 transposome. Localized reverse transcription generates RNA/cDNA hybrids that are subsequently tagmented by Tn5 transposases for downstream sequencing.

View Article and Find Full Text PDF

The regulatory elements controlling gene expression during acute inflammation are not fully elucidated. Here we report the identification of a set of NF-κB-bound elements and common chromatin landscapes underlying the acute inflammatory response across cell-types and mammalian species. Using primary vascular endothelial cells (human/mouse/bovine) treated with the pro-inflammatory cytokine, Tumor Necrosis Factor-α, we identify extensive (~30%) conserved orthologous binding of NF-κB to accessible, as well as nucleosome-occluded chromatin.

View Article and Find Full Text PDF

Atherosclerosis is a chronic inflammatory disease that is driven, in part, by activation of vascular endothelial cells (ECs). In response to inflammatory stimuli, the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway orchestrates the expression of a network of EC genes that contribute to monocyte recruitment and diapedesis across the endothelium. Although many long noncoding RNAs (lncRNAs) are dysregulated in atherosclerosis, they remain poorly characterized, especially in the context of human vascular inflammation.

View Article and Find Full Text PDF

Mechanisms that govern transcriptional regulation of inflammation in atherosclerosis remain largely unknown. Here, we identify the nuclear transcription factor c-Myb as an important mediator of atherosclerotic disease in mice. Atherosclerosis-prone animals fed a diet high in cholesterol exhibit increased levels of c-Myb in the bone marrow.

View Article and Find Full Text PDF
Article Synopsis
  • - CTCF is a key regulator for vascular development in mice, playing a crucial role in embryogenesis and limiting reactive oxygen species (ROS) accumulation in endothelial cells.
  • - Conditional knockout of CTCF in endothelial progenitors led to severe defects in yolk sac and placental vascular development, resulting in embryonic lethality by day 10.5.
  • - The study shows that CTCF deficiency causes ROS-mediated DNA damage in endothelial cells and suggests a link between CTCF function and endothelial dysfunction in diseases like Friedreich's ataxia.
View Article and Find Full Text PDF

Background: Sporadic arteriovenous malformations of the brain, which are morphologically abnormal connections between arteries and veins in the brain vasculature, are a leading cause of hemorrhagic stroke in young adults and children. The genetic cause of this rare focal disorder is unknown.

Methods: We analyzed tissue and blood samples from patients with arteriovenous malformations of the brain to detect somatic mutations.

View Article and Find Full Text PDF

Rationale: Inflammation is a key contributor to atherosclerosis. MicroRNA-146a (miR-146a) has been identified as a critical brake on proinflammatory nuclear factor κ light chain enhancer of activated B cells signaling in several cell types, including endothelial cells and bone marrow (BM)-derived cells. Importantly, miR-146a expression is elevated in human atherosclerotic plaques, and polymorphisms in the precursor have been associated with risk of coronary artery disease.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how vascular endothelial growth factor (VEGF) signaling activates transcriptional pathways during angiogenesis, focusing on the Notch ligand DLL4 in endothelial cells.
  • It finds that the MAPK/ERK pathway is crucial for the transcription of DLL4, requiring the phosphorylation and activation of the ETS transcription factor ERG.
  • Moreover, the research unveils a network of VEGF-responsive and ERG-dependent genes, supported by regulatory elements revealed through genome-wide profiling and editing techniques.
View Article and Find Full Text PDF

Emerging evidence suggests that long non-coding RNAs (lncRNAs) represent a cellular hub coordinating various cellular processes that are critical in health and disease. Mechanical stress triggers changes in vascular smooth muscle cells (VSMCs) that in turn contribute to pathophysiological changes within the vasculature. We sought to evaluate the role that lncRNAs play in mechanical stretch-induced alterations of human aortic smooth muscle cells (HASMCs).

View Article and Find Full Text PDF

Atherosclerosis is a vascular pathology characterized by inflammation and plaque build-up within arterial vessel walls. Vessel occlusion, often occurring after plaque rupture, can result in myocardial and cerebral infarction. Epigenetic changes are increasingly being associated with atherosclerosis and are of interest from both therapeutic and biomarker perspectives.

View Article and Find Full Text PDF

Cardiovascular diseases such as atherosclerosis are one of the leading causes of morbidity and mortality worldwide. The clinical manifestations of atherosclerosis, which include heart attack and stroke, occur several decades after initiation of the disease and become more severe with age. Inflammation of blood vessels plays a prominent role in atherogenesis.

View Article and Find Full Text PDF
Article Synopsis
  • Maintenance of blood vessel integrity is crucial for embryo development and organ function, but how this is regulated at the gene expression level is not well understood.
  • This study identifies the histone methyltransferase Ezh2 as a key player that prevents the activation of Mmp9, a gene that, if expressed, disrupts vascular stability during development.
  • In experiments with mice, inactivating Ezh2 led to severe vascular defects and embryonic death, but removing Mmp9 helped restore proper blood vessel structure, highlighting a significant link between Ezh2 and future vascular health.
View Article and Find Full Text PDF
Article Synopsis
  • Natural lipocyclocarbamate compounds have inspired the development of darapladib, a novel synthetic drug aimed at inhibiting phospholipase activity.
  • Darapladib is currently undergoing phase III clinical trials to evaluate its effectiveness in treating atherosclerosis.
  • The synthesis of these natural products is facilitated by a process involving nonribosomal peptide synthetase.
View Article and Find Full Text PDF

A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_sessionm085qn4f777tdk1atopg0v64so02dbg2): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once